Total Payments
$39,049
2024 Payments
$18,284
Companies
39
Transactions
700
Medicare Patients
1,143
Medicare Billing
$333,754
Payment Breakdown by Category
Food & Beverage$23,785 (60.9%)
Consulting$10,219 (26.2%)
Education$1,906 (4.9%)
Other$1,650 (4.2%)
Travel$1,489 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,785 | 680 | 60.9% |
| Consulting Fee | $10,219 | 5 | 26.2% |
| Education | $1,906 | 2 | 4.9% |
| Honoraria | $1,650 | 2 | 4.2% |
| Travel and Lodging | $1,489 | 11 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $9,590 | 259 | $0 (2024) |
| elliquence, LLC | $9,000 | 4 | $0 (2024) |
| Forte Bio-Pharma LLC | $3,260 | 64 | $0 (2024) |
| Spinal Simplicity, LLC | $3,128 | 31 | $0 (2024) |
| Medtronic, Inc. | $2,508 | 43 | $0 (2024) |
| BIOTRONIK NRO, Inc. | $2,070 | 43 | $0 (2024) |
| Vertos Medical, Inc. | $1,696 | 20 | $0 (2024) |
| Boston Scientific Corporation | $1,683 | 63 | $0 (2024) |
| PROTEGA PHARMACEUTIALS INC | $1,650 | 2 | $0 (2024) |
| Nevro Corp. | $1,290 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,284 | 172 | elliquence, LLC ($9,000) |
| 2023 | $4,328 | 131 | Forte Bio-Pharma LLC ($1,449) |
| 2022 | $4,676 | 128 | Medtronic, Inc. ($1,850) |
| 2021 | $5,269 | 73 | Spinal Simplicity, LLC ($2,360) |
| 2020 | $2,577 | 79 | Abbott Laboratories ($1,734) |
| 2019 | $2,225 | 69 | Abbott Laboratories ($1,375) |
| 2018 | $1,544 | 44 | Abbott Laboratories ($709.57) |
| 2017 | $144.22 | 4 | Nevro Corp. ($118.80) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $83.40 | General |
| Category: Neuromodulation | ||||||
| 12/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $67.85 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $114.96 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: Neuromodulation | ||||||
| 12/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Neuromodulation | ||||||
| 12/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Neuromodulation | ||||||
| 12/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Neuromodulation | ||||||
| 12/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Neuromodulation | ||||||
| 12/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Neuromodulation | ||||||
| 12/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Neuromodulation | ||||||
| 12/16/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $12.39 | General |
| 12/13/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $3.22 | General |
| Category: Opioid Analgesic | ||||||
| 12/11/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Neuromodulation | ||||||
| 12/11/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Neuromodulation | ||||||
| 12/11/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Neuromodulation | ||||||
| 12/10/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $9.50 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neuromodulation | ||||||
| 12/09/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: Neuromodulation | ||||||
| 12/04/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Not Applicable | ||||||
| 12/02/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: SPINAL HARDWARE | ||||||
| 11/29/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $187.79 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 337 | 1,167 | $672,475 | $126,513 |
| 2022 | 9 | 275 | 903 | $534,084 | $85,972 |
| 2021 | 9 | 257 | 792 | $400,431 | $71,091 |
| 2020 | 10 | 274 | 611 | $373,451 | $50,178 |
Total Patients
1,143
Total Services
3,473
Medicare Billing
$333,754
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 667 | $300,150 | $63,618 | 21.2% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 75 | 190 | $76,000 | $37,006 | 48.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 79 | 202 | $96,960 | $12,302 | 12.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 15 | 20 | $116,250 | $4,681 | 4.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $13,900 | $2,655 | 19.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 12 | 13 | $28,274 | $2,204 | 7.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 31 | $10,325 | $2,042 | 19.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 13 | 13 | $18,934 | $1,324 | 7.0% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 11 | 11 | $11,682 | $681.81 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 570 | $256,500 | $55,386 | 21.6% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 33 | 50 | $20,000 | $9,744 | 48.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 56 | 128 | $61,440 | $7,864 | 12.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 15 | 20 | $120,000 | $5,286 | 4.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 33 | $10,725 | $2,181 | 20.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 13 | 13 | $29,458 | $2,055 | 7.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $10,425 | $1,814 | 17.4% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 22 | 23 | $24,771 | $1,390 | 5.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 28 | 51 | $765.00 | $251.38 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 552 | $248,400 | $55,065 | 22.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $19,460 | $2,987 | 15.3% |
| 72275 | Radiological supervision and interpretation x-ray of covering of spinal cord | Office | 2021 | 14 | 23 | $16,118 | $2,662 | 16.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 16 | 16 | $35,044 | $2,518 | 7.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 29 | $9,425 | $1,987 | 21.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 18 | 18 | $26,556 | $1,901 | 7.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 27 | 30 | $14,400 | $1,864 | 12.9% |
About Dr. Russell Feit, M.D
Dr. Russell Feit, M.D is a Interventional Pain Medicine healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1942613989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Russell Feit, M.D has received a total of $39,049 in payments from pharmaceutical and medical device companies, with $18,284 received in 2024. These payments were reported across 700 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($23,785).
As a Medicare-enrolled provider, Feit has provided services to 1,143 Medicare beneficiaries, totaling 3,473 services with total Medicare billing of $333,754. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Pain Medicine
- Location Palm Beach Gardens, FL
- Active Since 06/07/2014
- Last Updated 08/15/2023
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1942613989
Products in Payments
- Disc-FX System (Device) $4,500
- PROCLAIM (Device) $3,415
- HA MINUTEMAN G3-R (Device) $3,128
- Proclaim Family of SCS IPGs (Device) $3,119
- NALOCET (Drug) $3,049
- mild Device Kit (Device) $1,696
- Prospera (Device) $1,643
- SYNCHROMEDII (Device) $1,535
- ETERNA (Device) $1,227
- Senza Spinal Cord Stimulation System (Device) $951.95
- Proclaim IPG (Device) $874.94
- XTAMPZA (Drug) $806.31
- INTELLIS ADAPTIVESTIM (Device) $572.86
- SUPERION (Device) $479.19
- BIOTRONIK (Device) $427.20
- Evoke (Device) $342.20
- SCS leads (Device) $292.82
- Axium INS DRG IPG (Device) $231.81
- Superion (Device) $215.30
- PROLATE (Drug) $211.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.